$65.8B
$206,000
0.0% of portfolio
3,664
Q3 2024
New
$71B
$22.6 Million
0.0% of portfolio
231,672
Q1 2025
Reduced 18.9%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 2.12%
$874M
$5.03 Million
0.0% of portfolio
581,975
Q1 2025
Reduced 5.13%
$152M
$3.18 Million
0.0% of portfolio
563,404
Q1 2025
Added 0.43%
$1.69B
$28.3 Million
0.0% of portfolio
1,545,260
Q1 2025
Reduced 2.97%
$786M
$10.4 Million
0.0% of portfolio
1,316,781
Q1 2025
Added 1.07%
$497M
$6.32 Million
0.0% of portfolio
223,181
Q1 2025
Added 5.22%
$696M
$12.5 Million
0.0% of portfolio
346,881
Q1 2025
Reduced 1.96%
$625M
$319,000
0.0% of portfolio
14,335
Q1 2025
New
$882M
$32.7 Million
0.0% of portfolio
5,835,950
Q1 2025
Reduced 7.62%
$2.7B
$74.1 Million
0.0% of portfolio
3,754,264
Q1 2025
Added 1.75%
$249M
$17.5 Million
0.0% of portfolio
1,842,800
Q1 2025
Reduced 16.55%
-
$0
0.0% of portfolio
-
Q4 2024
New
$172M
$2.95 Million
0.0% of portfolio
940,284
Q1 2025
Added 10.81%
-
$0
0.0% of portfolio
-
Q4 2024
Added 43.91%
$59.5M
$1.64 Million
0.0% of portfolio
900,636
Q1 2025
Reduced 1.06%
$45.8M
$133,000
0.0% of portfolio
43,863
Q4 2024
Reduced 2.01%
$1.08B
$44.1 Million
0.0% of portfolio
2,484,600
Q1 2025
Reduced 6.56%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 35.01%
$3.57B
$94.5 Million
0.0% of portfolio
3,245,108
Q1 2025
Reduced 3.75%
$94.3M
$1.49 Million
0.0% of portfolio
1,641,181
Q1 2025
Reduced 0.99%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 83.79%
$34.2B
$380,000
0.0% of portfolio
21,700
Q1 2025
Added 24.71%
$41.9M
$210,000
0.0% of portfolio
210,138
Q2 2024
Reduced 79.06%
$680M
$11.5 Million
0.0% of portfolio
296,093
Q1 2025
Reduced 1.08%
$821M
$27.3 Million
0.0% of portfolio
2,423,306
Q1 2025
Reduced 3.46%
$432M
$8.24 Million
0.0% of portfolio
509,194
Q1 2025
Reduced 1.05%
$1.24B
$50.2 Million
0.0% of portfolio
1,227,590
Q1 2025
Reduced 2.03%
Cartesian Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 16.51%
$622M
$14.3 Million
0.0% of portfolio
330,595
Q1 2025
Added 0.12%
$87.8M
$1.31 Million
0.0% of portfolio
873,946
Q1 2025
Reduced 12.31%
$44M
$165,000
0.0% of portfolio
156,000
Q1 2025
Added 212.63%
$512M
$14.3 Million
0.0% of portfolio
715,028
Q1 2025
Added 0.68%
$57.3M
$238,000
0.0% of portfolio
71,546
Q4 2024
Added 8.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 84.57%
$148M
$342,000
0.0% of portfolio
12,041
Q4 2024
Added 5.24%
$103M
$220,000
0.0% of portfolio
275,093
Q1 2025
Added 3.19%
$3.76B
$87.8 Million
0.0% of portfolio
1,157,702
Q1 2025
Reduced 0.62%
$813M
$16.4 Million
0.0% of portfolio
616,236
Q1 2025
Reduced 3.98%
$6.05B
$76.4 Million
0.0% of portfolio
8,461,645
Q1 2025
Added 7.25%
$0
$0
0.0% of portfolio
649,426
Q1 2025
Reduced 2.83%
$104M
$49,000
0.0% of portfolio
215,207
Q4 2024
Added 11.21%
$200M
$5.92 Million
0.0% of portfolio
585,180
Q1 2025
Reduced 33.49%
$1.05B
$50.9 Million
0.0% of portfolio
2,806,359
Q1 2025
Reduced 13.25%
$2.91B
$13.9 Million
0.0% of portfolio
715,022
Q1 2025
Added 20.97%
Cellectar Biosciences Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 9.67%
-
$0
0.0% of portfolio
-
Q4 2024
Added 145.7%
$10.7B
$8.86 Million
0.0% of portfolio
1,578,921
Q1 2025
Reduced 12.24%
-
$0
0.0% of portfolio
-
Q4 2024
New